CellaVision AB
OTC:CLVSF
CellaVision AB
Revenue
CellaVision AB
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
CellaVision AB
STO:CEVI
|
Revenue
kr708.3m
|
CAGR 3-Years
15%
|
CAGR 5-Years
13%
|
CAGR 10-Years
14%
|
|
Elekta AB (publ)
STO:EKTA B
|
Revenue
kr16.9B
|
CAGR 3-Years
5%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
Getinge AB
STO:GETI B
|
Revenue
kr31.8B
|
CAGR 3-Years
2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
Arjo AB (publ)
STO:ARJO B
|
Revenue
kr11B
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
Elos Medtech AB
STO:ELOS B
|
Revenue
kr888.5m
|
CAGR 3-Years
9%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
Sedana Medical AB (publ)
STO:SEDANA
|
Revenue
kr164.9m
|
CAGR 3-Years
3%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
See Also
What is CellaVision AB's Revenue?
Revenue
708.3m
SEK
Based on the financial report for Mar 31, 2024, CellaVision AB's Revenue amounts to 708.3m SEK.
What is CellaVision AB's Revenue growth rate?
Revenue CAGR 10Y
14%
Over the last year, the Revenue growth was 15%. The average annual Revenue growth rates for CellaVision AB have been 15% over the past three years , 13% over the past five years , and 14% over the past ten years .